Establishing a Primary Lung Cancer Model to Identify Mutant Subpopulations That Cause Resistance to Molecularly-targeted Cancer Therapies.

被引：0
|
作者：
Banda, M. [1 ]
McKim, K. L. [2 ]
Myers, M. B. [2 ]
Parsons, B. L. [2 ]
机构：
[1] Covance Labs Inc, Indianapolis, IN USA
[2] US FDA, NCTR, Div Genet & Mol Toxicol, Jefferson, AR USA
来源：
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
S46
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [41] ALCHEMIST: a clinical trial platform to bring genomic discovery and molecularly targeted therapies to early-stage lung cancer.
    Gerber, David E.
    Oxnard, Geoffrey R.
    Mandrekar, Sumithra J.
    Dahlberg, Suzanne Eleanor
    Malik, Shakun M.
    Mooney, Margaret M.
    Abrams, Jeffrey S.
    Janne, Pasi A.
    Li, Tianhong
    Ramalingam, Suresh S.
    Vokes, Everett E.
    Govindan, Ramaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Total mutation burden (TMB) in lung cancer (LC) and relationship with response to PD-1/PD-L1 targeted therapies.
    Spigel, David R.
    Schrock, Alexa Betzig
    Fabrizio, David
    Frampton, Garrett Michael
    Sun, James
    He, Jie
    Gowen, Kyle
    Johnson, Melissa Lynne
    Bauer, Todd Michael
    Kalemkerian, Gregory Peter
    Raez, Luis E.
    Ou, Sai-Hong Ignatius
    Ross, Jeffrey S.
    Stephens, Philip J.
    Miller, Vincent A.
    Ali, Siraj Mahamed
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Real-world data (RWD) on tumor response (rwTR) in advanced non-small cell lung cancer (aNSCLC) patients receiving cancer immunotherapy and targeted therapies.
    Lu, Michael
    Sadetsky, Natalia
    Lambert, Peter
    Whipple, Sam
    Taylor, Michael Dennis
    Riehl, Todd
    Riely, Gregory J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] APOBEC3A drives acquired resistance to targeted therapies in non small cell lung cancer.
    Isozaki, Hideko
    Abbasi, Ammal
    Nikpour, Naveed
    Langenbucher, Adam
    Su, Wenjia
    Stanzione, Marcello
    Sequist, Lecia V.
    Buisson, Remi
    Lawrence, Michael S.
    Hata, Aaron N.
    CANCER RESEARCH, 2021, 81 (13)
  • [45] Success of bronchoscopically extracted small cell lung cancer (SCLC) sample in establishing primary SCLC xenografts: A preclinical aerodigestive cancer model to establish biomarker profile and response to novel therapies
    Yung, RC
    Watkins, DN
    Daniel, VC
    Syphard, E
    Gessel, GS
    Ames, S
    Gabrielson, E
    Flint, P
    Berman, D
    Brock, MV
    Peacock, CD
    CHEST, 2005, 128 (04) : 153S - 154S
  • [46] An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
    Boumelha, Jesse
    Trecesson, Sophie de Carne
    Law, Emily K.
    Romero-Clavijo, Pablo
    Coelho, Matthew A.
    Ng, Kevin W.
    Mugarza, Edurne
    Moore, Christopher
    Rana, Sareena
    Caswell, Deborah R.
    Murillo, Miguel
    Hancock, David C.
    Argyris, Prokopios P.
    Brown, William L.
    Durfee, Cameron
    Larson, Lindsay K.
    Vogel, Rachel, I
    Suarez-Bonnet, Alejandro
    Priestnall, Simon L.
    East, Philip
    Ross, Sarah J.
    Kassiotis, George
    Molina-Arcas, Miriam
    Swanton, Charles
    Harris, Reuben
    Downward, Julian
    CANCER RESEARCH, 2022, 82 (19) : 3435 - 3448
  • [47] A Case of Small Cell Lung Cancer Transformation from EGFR-Mutant Lung Adenocarcinoma with Primary Resistance to Gefitinib
    Chu, Xiao
    Li, Yuan
    Zhu, Zhengfei
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : E211 - E214
  • [48] Structure-Guided Strategies of Targeted Therapies for Patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Du, Zhenfang
    Sun, Jinghan
    Zhang, Yunkai
    Hesilaiti, Nigaerayi
    Xia, Qi
    Cui, Heqing
    Fan, Na
    Xu, Xiaofang
    BIOMOLECULES, 2023, 13 (02)
  • [49] The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immunotherapy
    Shu, Chun-Lu
    Liu, Yu -Ling
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3485 - 3492
  • [50] Pdx model of pleural effusion of lung cancer patient for testing on targeted drug sensitivity and resistance
    Zhang, Feifei
    Zhou, Zhen
    Long, Yuan
    Xu, Wenhua
    Zhao, Shizhu
    Yang, Yang
    Liu, Hui
    Cheng, Jijun
    Lu, Shun
    Wen, Danyi
    CANCER RESEARCH, 2018, 78 (13)
12345